MA26690A1 - COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATION - Google Patents
COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATIONInfo
- Publication number
- MA26690A1 MA26690A1 MA25774A MA25774A MA26690A1 MA 26690 A1 MA26690 A1 MA 26690A1 MA 25774 A MA25774 A MA 25774A MA 25774 A MA25774 A MA 25774A MA 26690 A1 MA26690 A1 MA 26690A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- pyrazine
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 21/09/1998 60/101,191 US 12/10/1998 60/103,868 Voir en annexe le titre de l'invention et le texte de l'abrégé "Compositions pharmaceutiques contenant des dérivés de pyrido [1,2-a]pyrazine et procédé pour leur préparation' L'invention concerne des compositions pharmaceutiques contenant des composés de formule (I) dans laquelle X et Y représentent divers radicaux. Elle concerne également un procédé pour leur préparation. Application : Utilisation de ces compositions dans le traitement de la maladie de Parkinson, du trouble d'hyperactivite par défaut d'attention et de microadénomes chez des mammifères.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10119198P | 1998-09-21 | 1998-09-21 | |
| US10386898P | 1998-10-12 | 1998-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26690A1 true MA26690A1 (fr) | 2004-12-20 |
Family
ID=26798000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25774A MA26690A1 (fr) | 1998-09-21 | 1999-09-20 | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATION |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US6300329B1 (fr) |
| EP (1) | EP1115402A1 (fr) |
| JP (1) | JP2002526448A (fr) |
| KR (3) | KR20040054752A (fr) |
| CN (1) | CN1319013A (fr) |
| AP (1) | AP1456A (fr) |
| AR (1) | AR029739A1 (fr) |
| AU (1) | AU760230B2 (fr) |
| BG (1) | BG105445A (fr) |
| BR (1) | BR9913975A (fr) |
| CA (1) | CA2344670A1 (fr) |
| CO (1) | CO5140075A1 (fr) |
| CZ (1) | CZ20011006A3 (fr) |
| DZ (1) | DZ2894A1 (fr) |
| EA (2) | EA200100204A1 (fr) |
| EE (1) | EE200100179A (fr) |
| GE (1) | GEP20033081B (fr) |
| GT (1) | GT199900154A (fr) |
| HN (1) | HN1999000146A (fr) |
| HR (1) | HRP20010209A2 (fr) |
| HU (1) | HUP0103691A3 (fr) |
| ID (1) | ID28028A (fr) |
| IL (2) | IL164839A0 (fr) |
| IS (1) | IS5852A (fr) |
| MA (1) | MA26690A1 (fr) |
| MY (1) | MY127939A (fr) |
| NO (1) | NO20011409L (fr) |
| NZ (1) | NZ509855A (fr) |
| OA (1) | OA11653A (fr) |
| PA (1) | PA8482001A1 (fr) |
| PE (1) | PE20001084A1 (fr) |
| PL (1) | PL346904A1 (fr) |
| SK (1) | SK3592001A3 (fr) |
| TN (1) | TNSN99177A1 (fr) |
| TR (2) | TR200402083T2 (fr) |
| TW (1) | TW518225B (fr) |
| WO (1) | WO2000016777A1 (fr) |
| YU (1) | YU21701A (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1999000146A (es) * | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
| US8030294B2 (en) * | 2000-03-16 | 2011-10-04 | The Mclean Hospital Corporation | Compounds for the treatment of psychiatric or substance abuse disorders |
| GB0027020D0 (en) * | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| US7132287B2 (en) | 2001-06-18 | 2006-11-07 | Psychiatric Genomics, Inc. | Method for neural stem cell differentiation using 5HT-1A agonists |
| US20030036555A1 (en) * | 2001-08-03 | 2003-02-20 | Boehringer Ingelheim Pharma Kg | Pramipexole for the treatment of ADHD |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| US7737128B2 (en) * | 2004-06-10 | 2010-06-15 | The Mclean Hospital Corporation | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder |
| WO2006020703A1 (fr) * | 2004-08-11 | 2006-02-23 | The Mclean Hospital Corporation | Compose pour le traitement de la dependance, de la suppression et de l'usage de la marijuana |
| MY148644A (en) | 2005-07-18 | 2013-05-15 | Orion Corp | New pharmaceutical compounds |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| TW200800306A (en) | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
| GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| US9066903B2 (en) * | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
| WO2008083442A1 (fr) * | 2007-01-10 | 2008-07-17 | Brc Operations Pty Limited | Procédé pour la formulation de médicaments mixtes contre tdah |
| CN101318020B (zh) * | 2007-06-06 | 2011-09-28 | 四川科瑞德制药有限公司 | 抗焦虑或/和抗抑郁的药物组合物及用途 |
| US20100041621A1 (en) * | 2008-08-15 | 2010-02-18 | Perry Renshaw | Methods and compositions for improving cognitive performance |
| GB201112987D0 (en) | 2011-07-28 | 2011-09-14 | Ge Healthcare Ltd | Novel compound |
| WO2014078568A1 (fr) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Méthodes et compositions pour le traitement de la schizophrénie |
| WO2014172372A1 (fr) | 2013-04-15 | 2014-10-23 | Northwestern University | Traitement de troubles dopaminergiques |
| CN104892589A (zh) | 2014-03-07 | 2015-09-09 | 中国科学院上海药物研究所 | 一类杂环化合物、其制备方法和用途 |
| US11426366B2 (en) | 2015-05-15 | 2022-08-30 | Arizona Board Of Regents On Behalf Of The Universsity Of Arizona | Compositions and methods for treating motor disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX19222A (es) * | 1989-01-23 | 1993-12-01 | Pfizer | Agentes ansioliticos bis-aza-biciclicos |
| WO1992000075A1 (fr) * | 1990-06-29 | 1992-01-09 | Pfizer Inc. | Derives de pyridopyrazine utilises dans le traitement de l'abus et de la dependance de substances |
| US5281607B1 (en) * | 1992-10-08 | 1998-05-19 | Univ New York | Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases |
| GB9408084D0 (en) * | 1994-04-23 | 1994-06-15 | Boots Co Plc | Medical treatment |
| ES2163506T3 (es) * | 1994-06-14 | 2002-02-01 | Pfizer | Derivados de bencimidazolona con actividad dopaminergica central. |
| US5877183A (en) * | 1996-06-06 | 1999-03-02 | Ergo Research Corporation | Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists |
| HN1999000146A (es) * | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
-
1999
- 1999-08-27 HN HN1999000146A patent/HN1999000146A/es unknown
- 1999-09-03 GE GEAP19995812A patent/GEP20033081B/en unknown
- 1999-09-03 CN CN99811132A patent/CN1319013A/zh active Pending
- 1999-09-03 TR TR2004/02083T patent/TR200402083T2/xx unknown
- 1999-09-03 CA CA002344670A patent/CA2344670A1/fr not_active Abandoned
- 1999-09-03 BR BR9913975-8A patent/BR9913975A/pt not_active IP Right Cessation
- 1999-09-03 NZ NZ509855A patent/NZ509855A/xx unknown
- 1999-09-03 PL PL99346904A patent/PL346904A1/xx unknown
- 1999-09-03 WO PCT/IB1999/001503 patent/WO2000016777A1/fr not_active Application Discontinuation
- 1999-09-03 EP EP99939567A patent/EP1115402A1/fr not_active Withdrawn
- 1999-09-03 KR KR10-2004-7006381A patent/KR20040054752A/ko not_active Application Discontinuation
- 1999-09-03 EE EEP200100179A patent/EE200100179A/xx unknown
- 1999-09-03 ID IDW20010637A patent/ID28028A/id unknown
- 1999-09-03 AP APAP/P/2001/002102A patent/AP1456A/en active
- 1999-09-03 IL IL16483999A patent/IL164839A0/xx unknown
- 1999-09-03 JP JP2000573738A patent/JP2002526448A/ja active Pending
- 1999-09-03 AU AU53831/99A patent/AU760230B2/en not_active Ceased
- 1999-09-03 TR TR2001/01357T patent/TR200101357T2/xx unknown
- 1999-09-03 KR KR10-2003-7014169A patent/KR20030088512A/ko not_active Application Discontinuation
- 1999-09-03 KR KR10-2001-7003552A patent/KR100468340B1/ko not_active IP Right Cessation
- 1999-09-03 HU HU0103691A patent/HUP0103691A3/hu unknown
- 1999-09-03 IL IL14150799A patent/IL141507A0/xx unknown
- 1999-09-03 CZ CZ20011006A patent/CZ20011006A3/cs unknown
- 1999-09-03 OA OA1200100068A patent/OA11653A/en unknown
- 1999-09-03 EA EA200100204A patent/EA200100204A1/ru unknown
- 1999-09-03 SK SK359-2001A patent/SK3592001A3/sk unknown
- 1999-09-03 EA EA200301063A patent/EA200301063A1/ru unknown
- 1999-09-03 YU YU21701A patent/YU21701A/sh unknown
- 1999-09-13 GT GT199900154A patent/GT199900154A/es unknown
- 1999-09-15 TW TW088115941A patent/TW518225B/zh not_active IP Right Cessation
- 1999-09-15 PA PA19998482001A patent/PA8482001A1/es unknown
- 1999-09-17 AR ARP990104680A patent/AR029739A1/es unknown
- 1999-09-17 PE PE1999000948A patent/PE20001084A1/es not_active Application Discontinuation
- 1999-09-17 MY MYPI99004051A patent/MY127939A/en unknown
- 1999-09-20 TN TNTNSN99177A patent/TNSN99177A1/fr unknown
- 1999-09-20 MA MA25774A patent/MA26690A1/fr unknown
- 1999-09-20 DZ DZ990194A patent/DZ2894A1/fr active
- 1999-09-21 US US09/400,659 patent/US6300329B1/en not_active Expired - Fee Related
- 1999-09-21 CO CO99059863A patent/CO5140075A1/es unknown
-
2001
- 2001-02-20 IS IS5852A patent/IS5852A/is unknown
- 2001-03-20 NO NO20011409A patent/NO20011409L/no not_active Application Discontinuation
- 2001-03-20 HR HR20010209A patent/HRP20010209A2/hr not_active Application Discontinuation
- 2001-04-13 BG BG105445A patent/BG105445A/xx unknown
- 2001-05-03 US US09/848,068 patent/US6608064B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26690A1 (fr) | COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE PYRIDO [1,2-a ] PYRAZINE ET PROCEDE POUR LEUR PREPARATION | |
| MA26689A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA25035A1 (fr) | Derives de 3-azabicyclo [3,1,0] hexane nouveaux, procede pour leur preparation et compositions les contenant | |
| MA27451A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
| MA27676A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26733A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26727A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant | |
| MA26688A1 (fr) | 4-carboxamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA24729A1 (fr) | Macrolides nouveaux. | |
| MA26723A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA26720A1 (fr) | Composes nouveaux inhibiteurs de reabsorption de monoamines, procede pour leur preparation, et compositions pharmaceutiques les contenant. | |
| MA26701A1 (fr) | PYRAZOLOPYRIMIDINONES NOUVELLES INHIBITRICES DE PDE-5 GMPc, PROCEDE POUR LEUR PREPARATION ET COMPOSTIONS PHARMACEUTIQUES LES CONTENANT. | |
| MA27769A1 (fr) | Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique | |
| MA26718A1 (fr) | Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA27596A1 (fr) | Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation | |
| MA27439A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
| MA26700A1 (fr) | FORMULATIONS PHARMACEUTIQUES D'INHIBITEURS DE PDE-5 DE GMPc à LIBERATION CONTROLEE, ET PROCEDE POUR LEUR PREPARATION. | |
| TNSN97198A1 (fr) | Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant | |
| MA26703A1 (fr) | Macrolides antibiotiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| HUP0302635A2 (hu) | Valpronsav foszfolipidszármazékai és ezek keveréke | |
| HK1046902A1 (zh) | 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法 | |
| FR2716883B1 (fr) | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. | |
| MA24685A1 (fr) | Derives d'erythromycine tricycliques nouveaux, procede pour leur preparation et composition les contenant | |
| MA26721A1 (fr) | Derives de 2-aminopyridine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| CA2107485A1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |